Your browser doesn't support javascript.
loading
Age- and sex-specific analysis of patients with embolic stroke of undetermined source.
Ntaios, George; Lip, Gregory Y H; Vemmos, Konstantinos; Koroboki, Eleni; Manios, Efstathios; Vemmou, Anastasia; Rodríguez-Campello, Ana; Cuadrado-Godia, Elisa; Roquer, Jaume; Arnao, Valentina; Caso, Valeria; Paciaroni, Maurizio; Diez-Tejedor, Exuperio; Fuentes, Blanca; Pérez Lucas, Josefa; Arauz, Antonio; Ameriso, Sebastian F; Pertierra, Lucía; Gómez-Schneider, Maia; Hawkes, Maximiliano A; Bandini, Fabio; Chavarria Cano, Beatriz; Iglesias Mohedano, Ana Maria; García Pastor, Andrés; Gil-Núñez, Antonio; Putaala, Jukka; Tatlisumak, Turgut; Barboza, Miguel A; Athanasakis, George; Gioulekas, Fotios; Makaritsis, Konstantinos; Papavasileiou, Vasileios.
Afiliación
  • Ntaios G; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Lip GYH; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Vemmos K; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Koroboki E; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Manios E; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Vemmou A; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Rodríguez-Campello A; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Cuadrado-Godia E; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Roquer J; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Arnao V; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Caso V; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Paciaroni M; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Diez-Tejedor E; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Fuentes B; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Pérez Lucas J; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Arauz A; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Ameriso SF; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Pertierra L; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Gómez-Schneider M; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Hawkes MA; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Bandini F; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Chavarria Cano B; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Iglesias Mohedano AM; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • García Pastor A; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Gil-Núñez A; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Putaala J; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Tatlisumak T; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Barboza MA; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Athanasakis G; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Gioulekas F; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Makaritsis K; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
  • Papavasileiou V; From the Department of Medicine (G.N., G.A., K.M., V.P.), Larissa University Hospital, School of Medicine, University of Thessaly, Larissa, Greece; University of Birmingham Institute of Cardiovascular Sciences (G.Y.H.L.), City Hospital, UK; Department of Clinical Therapeutics (K.V., E.K., E.M., A.V.
Neurology ; 89(6): 532-539, 2017 Aug 08.
Article en En | MEDLINE | ID: mdl-28687720
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Isquemia Encefálica / Accidente Cerebrovascular / Embolia Intracraneal Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Neurology Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Isquemia Encefálica / Accidente Cerebrovascular / Embolia Intracraneal Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Neurology Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos